Substance / Medication

Bromocriptine mesylate

Overview

Active Ingredient
bromocriptine
RxNorm CUI
1760

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

56 trials linked to this intervention

56
Total Trials
7
Recruiting
17
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.
Gaziano J Michael, Cincotta Anthony H, Vinik Aaron et al. · J Am Heart Assoc · 2012
PMID: 23316290ObservationalFull text (PMC)
Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia.
Darwish Atef M, El-Sayed Ahmad M, El-Harras Suasan A et al. · Fertil Steril · 2008
PMID: 18462734Observational
Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus.
Siamashvili Maka, Davis Stephen · Expert Opin Pharmacother · 2021
PMID: 33030357Review
QbD and green metric based HPLC method development and validation of bromocriptine mesylate in bulk product and biological samples.
Saini Sumant, Kaur Ripandeep, Kaur Ranjot et al. · J Chromatogr B Analyt Technol Biomed Life Sci · 2025
PMID: 40262358Other
Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in HealthyChinese Subjects.
Song Huan, Chen Yujun, Chen Lianlian et al. · Clin Pharmacol Drug Dev · 2025
PMID: 41020775Other
Color change in Perlodeltablets induced by LED lighting - photolysis of bromocriptine mesylate.
Yamashita S, Iguchi K, Noguchi Y et al. · Pharmazie · 2019
PMID: 31109398Other
Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus.
Niafar Mitra, Pourafkari Leili, Shahsavarinia Kavus et al. · J Cardiovasc Thorac Res · 2016
PMID: 27069561OtherFull text (PMC)
Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.
Moore Mary Courtney, Smith Marta S, Swift Larry L et al. · Am J Physiol Endocrinol Metab · 2020
PMID: 32459527PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bromocriptine mesilate (substance)
SNOMED CT
46293006
UMLS CUI
C0546852
RxNorm CUI
1760

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

7
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
56
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Bromocriptine mesylate — Conditions, Biomarkers & Specialists | Healos | Ltrl